Ticker Scorecard - BEAM Basics Company: Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.39B Activated in VL: True Average Daily Range Avg Daily Range: $1.66 | 3.48% Avg Daily Range (30 D): $0.83 | 3.07% Avg Daily Range (90 D): $0.77 | 3.01% Institutional Daily Volume Avg Daily Volume: .81M Avg Daily Volume (30 D): .98M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 54 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 2,710 Avg Inst. Trade: $3.17M Avg Inst. Trade (30 D): $3.13M Avg Inst. Trade (90 D): $3M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.86M Avg Closing Trade (30 D): $5.4M Avg Closing Trade (90 D): $4.62M Avg Closing Volume: 121.94K     News Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Dec 8, 2024 @ 6:45 PM Beam Therapeutics Presents New Non-human Primate (... Source: N/A Dec 7, 2024 @ 4:30 PM Beam Therapeutics Announces New Data from BEACON P... Source: N/A Dec 6, 2024 @ 12:00 PM Beam Therapeutics Announces Appointment of Sravan ... Source: N/A Nov 24, 2024 @ 10:47 AM Down 47% Since March, Is CRISPR Therapeutics Stock... Source: Cory Renauer Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.58 $-1.17 $-1.11 Diluted EPS $-1.58 $-1.17 $-1.11 Revenue $ 349.64M $ 14.27M $ 11.77M Gross Profit $ $ $ Net Income / Loss $ -143.59M $ -96.67M $ -91.05M Operating Income / Loss $ -182.67M $ -106.5M $ -104.9M Cost of Revenue $ $ $ Net Cash Flow $ 59.02M $ -62.17M $ 4.62M PE Ratio